Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin (Q48955517)

17 February 2018

title

Interaction of calcium antagonists with cyclic AMP phosphodiesterases and calmodulin (English)

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

16 September 2023

P. M. Epstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6284165

16 September 2023

K. Fiss

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6284165

16 September 2023

R. Hachisu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6284165

16 September 2023

D. M. Andrenyak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6284165

16 September 2023

publication date

1 April 1982

1 reference

17 February 2018

14 April 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6284165

https://api.elsevier.com/content/article/PII:0006291X82910890?httpAccept=text/xml

16 September 2023

language of work or name

English

0 references

work available at URL

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

https://api.elsevier.com/content/article/PII:0006291X82910890?httpAccept=text/plain

16 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Biochemical and Biophysical Research Communications

16 September 2023

published in

1 reference

17 February 2018

volume

105

1 reference

17 February 2018

issue

3

1 reference

17 February 2018

page(s)

1142-1149

1 reference

17 February 2018

The cellular mechanism of action of nimodipine (BAY e 9736), a new calcium antagonist [proceedings]

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Verapamil: a review of its pharmacological properties and therapeutic use.

16 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

16 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Calcium entry blockers in cardiologic therapy

16 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications

16 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Regulation of myosin light chain kinase by reversible phosphorylation and calcium-calmodulin

16 September 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Purification and characterization of high-affinity cyclic adenosine monophosphate phosphodiesterase from dog kidney

16 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Purification of plant calmodulin by fluphenazine-Sepharose affinity chromatography

16 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

16 September 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Conformational transition accompanying the binding of calcium(2+) ion to the protein activator of 3',5'-cyclic adenosine monophosphate phosphodiesterase

16 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Effects of nifedipine, a potent calcium-antagonistic coronary vasodilator, on atrioventricular conduction and blood flow in the isolated atrioventricular node preparation of the dog

16 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships

16 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Cyclic Nucleotide Phosphodiesterases: Properties, Activators, Inhibitors, Structure–Activity Relationships, and Possible Role in Drug Development

16 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Selective inhibition of cyclic nucleotide phosphodiesterases by analogs of 1-methyl-3-isobutylxanthine

16 September 2023

25

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

The determination of enzyme inhibitor constants

16 September 2023

26

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

The Determination of Enzyme Dissociation Constants

16 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Inhibition of cyclic amp phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator

16 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Differential regulation of calcium-dependent and calcium-independent cyclic nucleotide phosphodiesterases from heart by palmitoylcarnitine and palmitoyl coenzyme A

16 September 2023

30

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Stimulation of enzyme activities by fragments of calmodulin

16 September 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Calcium-induced exposure of a hydrophobic surface on calmodulin

16 September 2023

32

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

Interaction of the antihypertensive drug felodipine with calmodulin

16 September 2023

34

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

A 113Cd NMR study of calmodulin and its interaction with calcium, magnesium and trifluoperazine

16 September 2023

35

1 reference

https://api.crossref.org/works/10.1016/0006-291X(82)91089-0

16 September 2023

Identifiers

1 reference

17 February 2018

1 reference

17 February 2018